We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Diabetes & Endocrinology

Anaerobutyricum soehngenii: A New Hope for Glycemic Control

MedXY Editorial Team•Oct 2, 2025•Diabetes & Endocrinology
cardiovascular healthdiabetesGlycemic Control

Introduction

Anaerobutyricum soehngenii, formerly known as Eubacterium hallii, is a next-generation beneficial microbe recognized for its ability to produce butyrate, a short-chain fatty acid associated with various health benefits, particularly in metabolic health. This study explores the effects of A. soehngenii on glycemic control and other markers of cardio-metabolic health in adults at risk for type 2 diabetes.

Study Overview

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Mortality and Morbidity After Below-Knee Amputation in Diabetes: Insights from a 25-Year English Cohort StudyThis large-scale England study reveals persistently high mortality after below-knee amputation in diabetes, with one-year mortality exceeding 23%, emphasizing the need for targeted interventions focused on older, female, and comorbid patienSep 17, 2026Global Trends in the Burden of Ischemic Stroke Attributable to Diabetes Versus Atrial FibrillationThis study analyzes global trends comparing ischemic stroke burdens linked to diabetes and atrial fibrillation, revealing a rising impact of diabetes-related stroke and highlighting the need for targeted interventions.Sep 12, 2026Charcot Neuro-Osteoarthropathy in Diabetes: High Risk of Hospitalization, Amputation, and Mortality Revealed by Regional Cohort StudyCharcot neuro-osteoarthropathy (CNO) in people with diabetes is linked to frequent emergency hospitalizations, substantial risk of limb amputation, and reduced survival, highlighting urgent need for intensified multidisciplinary care.Sep 5, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Bridging the Gap: Ensuring Outpatient Follow-Up After Emergency Department Visits for Diabetes
Less than half of diabetes patients discharged from the emergency department receive timely outpatient follow-up, underscoring critical care continuity gaps that require targeted interventions to improve outcomes.
Sep 1, 2026
Impact of the DASH4D Diet on Glycemic Biomarkers in Adults with Type 2 Diabetes: Insights from a Randomized Controlled Feeding TrialThe DASH4D diet, a tailored DASH-style intervention for diabetes, significantly improved key glycemic biomarkers including fructosamine, fasting glucose, and HbA1c compared to a typical American diet in adults with type 2 diabetes.Aug 29, 2026
HTD1801 Monotherapy Significantly Improves Glycemic Control and Cardiometabolic Health in Type 2 Diabetes: Results From a 56-Week Phase 3 TrialA phase 3 trial demonstrated that HTD1801 monotherapy significantly reduces HbA1c and improves cardiometabolic and inflammatory markers in patients with inadequately controlled type 2 diabetes, with sustained effects and a favorable safetyAug 25, 2026